{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:14:29Z","timestamp":1791101669769,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,15]]},"DOI":"10.1093\/infdis\/jir188","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T04:32:22Z","timestamp":1306211542000},"page":"1791-1801","source":"Crossref","is-referenced-by-count":435,"title":["Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202"],"prefix":"10.1093","volume":"203","author":[{"given":"Grace A.","family":"McComsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Kitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Daar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camlin","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen C.","family":"Jahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Tebas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Melbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Sax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"key":"key\n\t\t\t\t20170702141248_bib1","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170702141248_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1310\/hct0803-164","article-title":"The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naive HIV-1-infected patients","volume":"8","author":"Cassetti","year":"2007","journal-title":"HIV Clin Trials"},{"key":"key\n\t\t\t\t20170702141248_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3851\/IMP1502","article-title":"Initiation of antiretroviral therapy with efavirenz associated with decreases in 25 Hydroxyvitamin D","volume":"15","author":"Brown","year":"2010","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170702141248_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients","volume":"23","author":"Duvivier","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib6","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170702141248_bib7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib8","volume-title":"Higher and increasing rates of fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared o the general US population, 1994 to 2008. 17th Conference on Retrovirus and Opportunistic Infections","author":"Dao","year":"2010"},{"key":"key\n\t\t\t\t20170702141248_bib9","volume-title":"HIV-infection and fragility fracture risk among male Veterans. 17th Conference on Retroviruses and Opportunistic Infections; 2010 February 18","author":"Womack","year":"2010"},{"key":"key\n\t\t\t\t20170702141248_bib10","volume-title":"Simplification with fixed-dose tenofovir-emtricitaine or abacavir-lamivudine in adults with suppressed HIV repliation (The Steal Study): a randomized, open-label, 96-week, non-inferiority trial. 16th Conference on Retroviruses and Opportunistic Infections 2009 February 8\u201311","author":"Cooper","year":"2010"},{"key":"key\n\t\t\t\t20170702141248_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study","volume":"51","author":"Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702141248_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/498505","article-title":"Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients","volume":"42","author":"Jemsek","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702141248_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/01.aids.0000244200.11006.55","article-title":"Effects of atazanavir\/ritonavir and lopinavir\/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically","volume":"20","author":"Noor","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib14","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa0906768","article-title":"Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy","volume":"361","author":"Sax","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170702141248_bib15","volume-title":"Simplicication with fixed-dose tenofovir-emtricitaine or abacavir-lamivudine in adults with suppressed HIV replication (The Steal Study): a randomized, open-label, 96-week, non-inferiority trial. 16th Conference on Retroviruses and Opportunistic Infections; 2009 February 8\u201311","author":"Cooper","year":"2009"},{"key":"key\n\t\t\t\t20170702141248_bib16","volume-title":"Effects of randomized regimen and nucleoside reverse transcriptase inhibitor (NRTI) selection on 96 week bone mineral density (BMD): results from ACTG 5142. Study Team is a Vienna Meeting","author":"Huang","year":"2010"},{"key":"key\n\t\t\t\t20170702141248_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170702141248_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1359\/JBMR.0301246","article-title":"BMD is reduced in HIV-infected men irrespective of treatment","volume":"19","author":"Amiel","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20170702141248_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/135965350801300803","article-title":"Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study","volume":"13","author":"Fux","year":"2008","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170702141248_bib20","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1124\/mol.108.053660","article-title":"Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells","volume":"75","author":"Ellfolk","year":"2009","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t20170702141248_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0b013e32832bab0f","article-title":"Efavirenz and bone health","volume":"23","author":"Fabbriciani","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/QAD.0b013e32831f4685","article-title":"Efavirenz-induced osteomalacia","volume":"23","author":"Herzmann","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib23","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/ijc.23197","article-title":"Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma","volume":"122","author":"Landriscina","year":"2008","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20170702141248_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mcp.2002.124519","article-title":"Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans","volume":"72","author":"Mouly","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t20170702141248_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00002030-200303070-00006","article-title":"HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D","volume":"17","author":"Cozzolino","year":"2003","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00002030-200303070-00006","article-title":"HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D","volume":"17","author":"Cozzolino","year":"2003","journal-title":"AIDS."},{"key":"key\n\t\t\t\t20170702141248_bib27","first-page":"39","article-title":"Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy","volume":"48","author":"Madeddu","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20170702141248_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170702141248_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00705-004-0395-7","article-title":"HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity","volume":"150","author":"Fakruddin","year":"2005","journal-title":"Arch Virol"},{"key":"key\n\t\t\t\t20170702141248_bib31","volume-title":"HIV-1 induces apoptosis in primary osteoblasts: an alternative mechanism in the development of osteopenia and osteoporosis. 15th Conference on Retroviruses and Opportunistic Infections 2009 February;","author":"Borderi","year":"2009"},{"key":"key\n\t\t\t\t20170702141248_bib32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jmv.21266","article-title":"HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation","volume":"80","author":"Gibellini","year":"2008","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170702141248_bib33","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1016\/8756-3282(95)00180-L","article-title":"Role of cytokines in bone resorption","volume":"17","author":"Manolagas","year":"1995","journal-title":"Bone"},{"key":"key\n\t\t\t\t20170702141248_bib34","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1007\/BF01673412","article-title":"Role of cytokines in the regulation of bone resorption","volume":"53","author":"Roodman","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t20170702141248_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis","volume":"11","author":"Pacifici","year":"1996","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20170702141248_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2007-1876","article-title":"Bone mineral density changes during the menopause transition in a multiethnic cohort of women","volume":"93","author":"Finkelstein","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170702141248_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s001980200001","article-title":"Changes in bone mineral density with age in men and women: a longitudinal study","volume":"13","author":"Warming","year":"2002","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t20170702141248_bib38","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","article-title":"Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir","volume":"15","author":"Nolan","year":"2001","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170702141248_bib39","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2006-0127","article-title":"Longitudinal analysis of bone density in human immunodeficiency virus-infected women","volume":"91","author":"Dolan","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/203\/12\/1791\/18064188\/jir188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:59:27Z","timestamp":1686095967000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jir188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,6,15]]},"published-print":{"date-parts":[[2011,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jir188","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,15]]}}}